Now CE-marked and cleared for commercialization in the EU
To learn more, click here

Addressing major challenges
in antimicrobial therapies
through cutting-edge
technology and research.

Our proprietary technology is designed
to reduce bioburden and improve patient outcomes.

Learn more

In the face of the biggest healthcare crisis in history, we asked ourselves how can we help…

Creating a more human, meaningful, and healthier world for all,
through cutting edge technology and research.

About

Established in 2022, Polaroid Therapeutics is driven by a clear and ambitious mission – to create a more human and meaningful world through groundbreaking technology and research.

 

Our proprietary technology is carefully crafted to tackle significant challenges in antimicrobial therapies, ultimately leading to improved patient outcomes.

 

At Polaroid Therapeutics, we are dedicated to making a positive impact on the lives of patients and their families. Our focus is on delivering superior treatments that promote healing and enhance the overall quality of life. We are committed to reaching and assisting individuals worldwide, with the vision of touching and improving the lives of all humankind.

Our Proprietary
Technology.

A new era of wound care.

Our proprietary technology represents a significant advancement in antimicrobial therapies, setting a new standard in the industry. We are committed to delivering superior solutions that not only effectively addresses bioburden of resistant strains but also ensures patient safety and optimal healing outcomes.

Enhancing Safety

Pushing the boundaries of medical devices to ensure a safer and healthier future for patients. Infection risk is a constant concern with medical devices such as catheters and implants. By developing long-lasting coatings that effectively combat bioburden and antimicrobial resistance (AMR), we are committed to lowering the risks associated with routine and complex medical procedures.

A Holistic Antimicrobial Breakthrough

Embracing cutting-edge 3D printing, Artificial Intelligence, combination drugs and advanced delivery systems, our mission is to introduce groundbreaking antimicrobial treatments to the world. Through our innovative technology, we strive to deliver superior and effective treatments that can transform patient outcomes.

Meet our small
but mighty team.

Ran
Frenkel, RPh

CEO & Co-Founder

Over 25 years of expertise in pharma executive management, research & development, clinical operations, regulatory, strategy & innovation. A seasoned leader with international roles, spanning from start-ups to biotech, medical device companies, CROs, and pharmaceutical companies.

Anne
Graham

COO & CO-FOUNDER

Commercial professional with expertise in branding, communications, marketing partnerships and business development. A breadth of experience from working across varied industries including global brands, media entities, technology, entertainment, NGOs, international and domestic sports properties.

Itai
Frenkel

Operations and Marketing Manager

A strategic and solutions-driven professional with expertise in global operations, marketing, and project management. Focused on bridging science, business, and communication to drive innovation and impactful outcomes.

Markus
Rothmaier

Head of Research and Development

Professional R&D manager with a proven track record of managing product development projects in the medical device and life science industry. Experienced in cross-functional team leadership, innovation and technology management.

Get acquainted with our
trusted Advisory Board.

Jeff
Hart, PhD

CEO and Founder of Cica Biomedical Ltd (established in 2001) a providing contract pre-clinical research services to the wound management and regenerative medicine sectors. 30 years’ experience running efficacy, translational and regulatory wound healing studies on devices, drugs and biologics. He has supported the progression of numerous wound therapies from the bench to clinical use.

Prof. Matthew
Hardman, PhD FRSB

A leading expert in wound healing and wound microbiology and Director of Research at Hull York Medical School. Mat brings unrivalled expertise in wound infection and delayed translational cell and tissue models.

Prof. Amit
Gefen PhD

Full Professor at Tel Aviv University, specializes in biomechanics and chronic wound research. Editor-in-Chief of Clinical Biomechanics, he chaired expert panels on pressure ulcer prevention and device-related injuries, shaping international guidelines and advancing biomedical engineering.

Addressing major challenges in antimicrobial therapies
through cutting-edge technology and research.

Find our Current Openings

Computational Discovery Scientist

Computational Discovery Scientist

Schlieren, Switzerland/ Remote

The Role

As an early scientific hire, you will work closely with the Head of Predict4IBD to establish and develop the company’s discovery pipeline. The role centres on building robust, reproducible workflows to identify, access, and analyse IBD-relevant omics datasets, with the goal of generating novel biomarker candidates that support P4IBD’s intellectual property and product development strategy.

You will also contribute to the company’s academic research partnerships, working with leading IBD research groups to plan studies, perform analyses and support the preparation of scientific reports and publications. Findings from your work will directly inform internal research priorities and the selection and scope of external collaborations.

This is a highly autonomous role with end‑to‑end ownership of scientific projects, suited to a computational scientist who can drive analyses forward and translate results into clear, actionable outcomes for the business.

Core Responsibilities

  • Identify, evaluate, and access omics datasets relevant to Predict4IBD’s biomarker discovery and development programmes
  • Design, implement, and maintain scalable, reproducible, version‑controlled analysis pipelines to support discovery‑stage biomarker identification.
  • Develop and apply machine‑learning–based frameworks to prioritise biomarker candidates across multiple datasets and relevant literature
  • Lead the analytical components of internal Predict4IBD biomarker studies and collaborative projects with academic and industry partners
  • Present analytical findings, prepare technical reports, and contribute to the preparation of scientific publications
  • Develop and maintain the initial Predict4IBD R&D computing environment, including cloud‑based infrastructure for computation, data storage, transfer, and backup

Required Skills & Experience

  • PhD in bioinformatics, computational biology, systems biology, or a closely related field, or equivalent industry experience
  • Proficiency in Bash, Python, and/or R for data analysis and pipeline development
  • Demonstrated experience analysing omics datasets and translating results into scientific insight
  • Familiarity with major public bioinformatics repositories and associated data access processes
  • Strong grounding in statistical methods and concepts relevant to biomedical & omic data analyses, including statistical power, confounding, regression modelling, binary classification models, clustering and cross-validation
  • Experience with version control (e.g. Git) and reproducible research practices
  • Ability to work independently, manage priorities, and progress multiple analyses in parallel

Advantageous Skills & Experience

  • Experience working in IBD, autoimmune, or other inflammatory disease areas
  • Experience in omics-based clinical biomarker development in large, heterogenous datasets
  • Hands-on proteomics data analysis experience e.g. MS, Olink, Somalogic, Nulisa
  • Publication record in clinical omics, systems biology or computational biology
  • Interest or exposure to biomedical product development
  • Experience using workflow managers (e.g. Nextflow, Snakemake, or equivalent) for validated and scalable pipeline implementation
  • Familiarity with cloud computing environments (e.g. AWS, Azure) and associated data governance practices

What We Offer

  • An early scientific role at Predict4IBD, with significant responsibility for analytical outputs that directly inform IP strategy and partnership development in next‑generation IBD diagnostics
  • Exposure to the scientific, translational, and strategic aspects of building an early‑stage commercial diagnostics programme
  • Competitive remuneration and potential for remote working across European time zones
  • Opportunities to travel to scientific conferences and meetings with co-workers and partners

Location & Practicalities

  • Full time, on-site or potential to be fully remote
  • CHF 50,000 – 60,000 gross salary per annum or currency equivalent
  • Start date: Q2 2026 (as early as possible)
How to Apply Please email a copy of your CV and a cover letter to careers@polaroidtx.com with the job title in the subject line

Research Operations Associate

Schlieren, Switzerland/ Remote

About Polaroid Therapeutics & Predict4IBD

Polaroid Therapeutics is a Swiss-based biotech start-up in the development of innovative antimicrobial technology. Incubated and developed by Polaroid—the brand that pioneered the complex chemistry and technology behind analog instant photography. Polaroid Therapeutics’ mission is to create human centric medical solutions based on its advancements in science and technology. Founded in 2022, PTx has developed APT™ (Antimicrobial Polymer Technology), a platform that enables controlled antimicrobial performance through structural design rather than chemical release. APT™ integrates proprietary polymer chemistry that can be adapted across multiple formats and clinical contexts, reflecting the company’s focus on responsible innovation, regulated evidence, and long-term antimicrobial resistance (AMR) stewardship.

Predict4IBD (P4IBD) is a newly established division of Polaroid Therapeutics, dedicated to developing and commercialising diagnostic tests that will transform the management of inflammatory bowel disease (IBD). Our mission is to harness advances across biology, computation and data analytics to deliver the next generation of precision diagnostics—enabling improved prediction of disease trajectory, treatment response and disease monitoring in IBD. We are a small, highly ambitious team working at the interface of cutting‑edge IBD science and clinical diagnostics. Joining P4IBD at this early, formative stage offers a unique opportunity to work closely with company leadership and to play a meaningful role in shaping the scientific direction and long‑term impact of the organisation.

The Role

We are seeking a capable, organised individual with a grounding in biomedical science to support the day‑to‑day research and business operations of Predict4IBD. This is a varied, hands‑on role suited to someone approximately 2–3 years post‑graduate who is looking to build experience within the biomedical industry, but we are open to all experience levels for those looking to join an rapid-growth start up.

You will work closely with the Head of Predict4IBD to support research partnerships, coordinate vendor relationships, and manage essential administrative and operational processes that enable projects to run efficiently. As an early hire, the role offers significant exposure to the inner workings of a growing biotech programme, with opportunities to help establish practical processes and to gain experience across scientific, operational, and commercial aspects of the business.

Core Responsibilities

  • Support and help develop day-to-day research and business operations, working closely with scientific leadership to keep projects progressing efficiently
  • Coordinate and manage relationships with external partners and vendors, including quotes, contracts, documentation, and invoicing processes
  • Help develop simple operational systems for tracking projects, timelines, costs, and external engagements
  • Support the preparation of reports, summaries, and materials for internal decision making, partners, and external stakeholders
  • Contribute to the operation and improvement of internal documentation systems across research, financial, and administrative activities
  • Take ownership of ad hoc operational projects and problem-solving tasks as the company evolves

Required Skills & Experience

  • Degree in biomedical science, biology, biochemistry, or a closely related field (BSc or equivalent)
  • Relevant work experience, a minimum of 2–3 years of experience, ideally in, a research, operations, or support role within biotech, pharmaceuticals, diagnostics, or a related environment
  • Strong organisational skills — able to manage multiple workstreams, track deadlines, and follow through independently
  • Clear and professional written communication skills, including drafting correspondence, project updates and briefing materials
  • Comfortable engaging with scientific content and familiar with the language of academic research and the biomedical industry
  • Proficiency with standard productivity and IT tools (e.g. MS Office and web-based collaboration platforms)

Advantageous Skills & Experience

  • Interest in diagnostics, precision medicine, autoimmunity, or inflammatory bowel disease research
  • Familiarity with clinical research operations, study coordination, or project management in a diagnostics or biomarker context
  • Experience supporting budget preparation, cost tracking, or basic financial workflows
  • Understanding of internal knowledge‑base or documentation systems (e.g. SharePoint or similar platforms)
  • Exposure to contract administration or coordination, including agreements such as Sponsored Research Agreements, CDAs, MTAs, or CRO/vendor contracts
  • Awareness of regulatory or compliance-driven environments (e.g. GCP, ISO)

What We Offer

  • An early research-operations role within the newly established Predict4IBD division of Polaroid Therapeutics
  • Close working relationship with the Head of P4IBD in a small, focused organisation, with meaningful responsibility from the outset
  • Exposure to scientific research, external partnerships, product commercialisation and the operational foundations of an early-stage diagnostics programme
  • Competitive remuneration package commensurate with experience
  • Primarily an office-based role, with hybrid working opportunities and scope for professional development as the company scales

Location & Practicalities

  • Full time, office-based in Schlieren, Zurich or remote working options
  • CHF 45,000-55,000 gross salary per annum or currency equivalent
  • Start date: Q2 2026 (as early as possible)

How to Apply

Please email a copy of your CV and a cover letter to careers@polaroidtx.com with the job title in the subject line.

Polaroid Therapeutics is an equal opportunity employer. We are a small team and we hire for quality, curiosity, and fit. If you are uncertain whether you meet every criterion, we encourage you to apply.